510(k) K150617

cobas HSV 1 and 2 Test by Roche Molecular Systems, Inc. — Product Code OQO

K150617 is an FDA 510(k) premarket notification submitted by Roche Molecular Systems, Inc. for the device "cobas HSV 1 and 2 Test". The FDA issued a decision of Substantially Equivalent on Jun 1, 2015. The device falls under product code OQO (Herpes Simplex Virus Nucleic Acid Amplification Assay), a Class II device regulated under 21 CFR 866.3305. Roche Molecular Systems, Inc. has 54 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jun 1, 2015
Date Received
Mar 10, 2015
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Herpes Simplex Virus Nucleic Acid Amplification Assay
Device Class
Class II
Regulation Number
866.3305
Review Panel
MI
Submission Type
510(k)

A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens.

Need the full FDA record for Roche Molecular Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K150617. Report a data issue: hello@regdatalab.com.